JAMIE JORDAN: Open Payments
NPI 1306369863 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 13 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $166 |
| ABBVIE INC. | 1 | $75 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $56 |
| Novo Nordisk Inc | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| AtriCure, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
Products named: CARDIOMEMS, QULIPTA, LifeVest, Wegovy, FARXIGA, CAPVAXIVE, SYNERGY ABLATION SYSTEM, VERQUVO.
Industry payments across KY — which companies pay providers there.
